PTT1E11 has been used to:
Study cross-reactivity with related coronaviruses (e.g., Porcine Respiratory Coronavirus [PRCV]) .
Characterize antigenic drift in porcine coronavirus S proteins, which informs vaccine design .
TGEV and PRCV share ~96% S protein homology, but PTT1E11 shows higher affinity for TGEV due to epitope differences in the S1 N-terminal domain .
No cross-reactivity with SARS-CoV-2 S protein, as TGEV utilizes porcine aminopeptidase N (pAPN) instead of ACE2 for entry .
Studies comparing PTT1E11 with other anti-TGEV antibodies reveal:
Antibody | Epitope Region | Neutralization Efficacy | Cross-Reactivity |
---|---|---|---|
PTT1E11 | S1 NTD | Moderate | TGEV-specific |
6AC3 | S1 RBD | High | TGEV, PRCV (partial) |
4F9 | S2 fusion peptide | Low | TGEV only |
NTD = N-terminal domain; RBD = receptor-binding domain.
In vivo models: PTT1E11 has been employed to track TGEV replication in piglet intestinal tissues, revealing viral tropism for duodenal and jejunal enterocytes .
Immune evasion: TGEV S protein mutations (e.g., Y681H) reduce PTT1E11 binding efficiency, highlighting evolutionary pressures on epitope regions .
The antibody was developed using purified porcine coronavirus clone PTT1E11. (eptopoe not mapped)
IgG2a
Porcine coronaviruses (SCoVs) include several important pathogens that significantly impact swine health globally. These viruses belong to different genera within the Coronaviridae family:
Alphacoronaviruses: Transmissible gastroenteritis virus (TGEV), Porcine epidemic diarrhea virus (PEDV), Porcine respiratory coronavirus (PRCV), and Swine acute diarrhea syndrome coronavirus (SADS-CoV)
Betacoronaviruses: Porcine hemagglutinating encephalomyelitis virus (PHEV)
Deltacoronaviruses: Porcine deltacoronavirus (PDCoV)
These viruses primarily affect the gastrointestinal, cardiovascular, and nervous systems of pigs, with infections causing particularly high mortality in piglets compared to adult swine . Their classification provides important context for understanding their biological properties, structural features, and evolutionary relationships.
Porcine coronavirus spike proteins are class I viral fusion proteins that exist as homotrimers on the viral surface. Each spike protein consists of two major functional subunits:
S1 subunit: Located at the N-terminus, responsible for receptor binding
S2 subunit: Located at the C-terminus, responsible for membrane fusion
The S1 subunit typically contains two domains:
N-terminal domain (S1-NTD): Often involved in binding to sugar/sialic acid receptors
C-terminal domain (S1-CTD): Often involved in binding to protein receptors
These structural characteristics are critical for viral entry and represent important targets for antibody neutralization and vaccine development.
Porcine coronavirus spike proteins mediate viral entry through a multistep process that involves:
Receptor recognition: The S1 subunit binds to specific host cell receptors. For example, PEDV has been shown to bind to sialic acid glycans using its S1 domain 0 .
Conformational changes: Following receptor binding, the spike protein undergoes progressive destabilization of its prefusion structure, triggering conformational changes that expose the fusion machinery in the S2 subunit .
Proteolytic activation: Host proteases cleave the spike protein at specific sites, further facilitating the fusion process. In betacoronavirus spikes, the S1 and S2 regions are often demarcated by a protease cleavage site, although this site is lacking in many alphacoronavirus spikes, including PEDV .
Membrane fusion: The S2 subunit mediates the fusion of viral and cellular membranes, allowing the viral genome to enter the host cell.
This process shares structural and functional parallels with other class I fusion proteins such as influenza hemagglutinin and HIV-1 Env, which proceed from metastable prefusion conformations to highly stable postfusion conformations .
Several sophisticated molecular features contribute to maintaining the prefusion conformation of porcine coronavirus spike proteins:
Non-protein components mediating protein-protein interfaces: Cryo-EM studies of the PEDV spike reveal that several protein-protein interfaces are mediated by:
Domain organization: The S1 regions of the homotrimeric spike surround and cap the C-terminal S2 regions, creating a metastable prefusion conformation that is primed for fusion triggering .
Structural configuration: The PEDV spike reveals a configuration similar to that of HuCoV-NL63, providing insights into shared stability determinants across alphacoronaviruses .
Understanding these stabilizing features has significant implications for designing stabilized spike proteins as vaccine immunogens, as modifications to these features can impact prefusion stability and potentially improve immune responses in vaccine formulations.
Porcine coronaviruses exhibit diverse receptor-binding properties that influence their host range and tissue tropism:
PEDV: Binds to sialic acid glycans using its S1 domain 0 . While initially proposed to recognize porcine aminopeptidase N (pAPN) by analogy with TGEV, recent studies have questioned this assumption . Interestingly, the sialic acid-binding site of PEDV differs from that of betacoronavirus OC43, suggesting an altered mode of glycan recognition despite structural homology between the domains .
PDCoV: Can infect cells from different animal and avian species, suggesting it utilizes a broadly expressed receptor or has evolved to recognize multiple receptors . This broad host range has implications for its potential for cross-species transmission.
SADS-CoV: Receptor usage remains under investigation, but genetic similarity to bat coronavirus HKU2 suggests it may use similar receptors .
TGEV: Uses pAPN as its primary receptor, a property that distinguishes it from some other porcine coronaviruses.
Field isolates and tissue-culture-adapted PEDV strains sometimes exhibit deletions in the S1 domain 0, leading to loss of sialic acid-binding activity . These variations in receptor usage and binding domains contribute to the diverse pathogenic properties of porcine coronaviruses.
Structural studies have identified specific antibody epitopes on porcine coronavirus spike proteins, providing valuable insights for vaccine development and diagnostic test design:
For PEDV, electron microscopy examination of sera from experimentally infected pigs revealed that antibodies primarily target two epitopes in the S1 region :
Apex epitope: Located at the spike apex, primarily contacting the membrane-distal loops of S1 domain A and possibly contacting select loops of domain B .
Side epitope: Located on the side of the PEDV spike, bridging S1 domains C and D .
Notably, all three sera examined from experimentally infected pigs contained spike-specific antibodies targeting these same two epitopes, suggesting these are immunodominant regions during natural infection . At least one of these epitopes overlaps with a known neutralizing antibody epitope, indicating that natural infection induces antibodies with potential neutralizing activity .
Understanding the locations of these immunodominant epitopes provides crucial information for designing subunit vaccines that present these regions in their native conformation to elicit protective antibody responses.
Multiple complementary structural biology techniques have proven valuable for studying porcine coronavirus spike proteins:
Cryo-electron microscopy (cryo-EM): This technique has been successfully used to determine high-resolution structures of porcine coronavirus spike proteins:
Negative-stain electron microscopy (EM): Used effectively to visualize antibody binding to spike proteins and map epitopes. For example, this approach was used to examine how Fabs derived from immunoglobulin G of PEDV-infected pigs bound to recombinant PEDV spike proteins .
Protein engineering for structural studies: Successful structural studies have employed specific strategies to prepare spike proteins:
Expression of the spike ectodomain (S-e) without the transmembrane anchor or intracellular tail
Exclusion of the hydrophobic pretransmembrane region to improve protein solubility
Addition of a GCN4 trimerization tag followed by a His6 tag for purification
Expression in insect cells followed by purification to homogeneity
Epitope mapping for porcine coronavirus spike proteins can be conducted using several complementary approaches:
Structural approaches:
Negative-stain electron microscopy: This technique has been successfully used to visualize complexes between porcine coronavirus spike proteins and Fabs derived from infected animals. For PEDV, this approach revealed two dominant epitopes in the S1 region through extensive 3D classification of EM data .
Cryo-electron microscopy: Provides higher resolution visualization of antibody-antigen interactions when suitable samples can be prepared.
Biochemical and molecular approaches:
Competitive binding assays: Using pairs of antibodies to determine if they compete for binding, indicating overlapping epitopes.
Deletion mutants and chimeric proteins: Creating spike constructs with domain swaps or deletions to localize binding regions.
Alanine-scanning mutagenesis: Systematically mutating surface residues to identify those critical for antibody recognition.
Functional characterization:
Neutralization assays: Correlating epitope binding with virus neutralization to identify functionally important epitopes.
Receptor blocking assays: Determining if antibodies interfere with receptor binding.
For porcine coronavirus research, the combination of these approaches has successfully identified immunodominant epitopes in natural infection scenarios, providing valuable insights for vaccine design and diagnostic development.
Several advanced strategies can be employed to develop improved antibodies against porcine coronavirus spike proteins:
Structure-guided antibody engineering:
Using structural information about the PTT1E11 antibody and other characterized antibodies to optimize binding affinity and specificity
Grafting complementarity-determining regions (CDRs) from highly neutralizing antibodies onto stable antibody frameworks
In vitro display technologies:
Phage display libraries to screen for high-affinity binders to specific spike domains
Yeast or mammalian display systems to evolve antibodies with enhanced properties
Ribosome display for generating antibodies with unique binding characteristics
Immunization strategies for generating superior antibodies:
Using stabilized prefusion spike proteins as immunogens to elicit antibodies against neutralization-sensitive epitopes
Sequential immunization with engineered spike variants to guide antibody maturation
Prime-boost strategies combining different immunogen forms
Target-specific approaches:
Developing antibodies specifically targeting the S1-NTD sialic acid binding site to block attachment
Generating antibodies against conserved regions in S2 to interfere with the fusion machinery
Creating bispecific antibodies that simultaneously target multiple epitopes
Antibody isolation and screening:
Single B-cell sorting from infected or immunized animals to isolate naturally occurring neutralizing antibodies
High-throughput neutralization screening to identify functionally potent antibodies
These approaches can lead to the development of antibodies with enhanced neutralization potency, broader cross-reactivity, and improved stability compared to naturally occurring antibodies or first-generation monoclonal antibodies like PTT1E11.
Based on successful approaches documented in the literature, the following represents optimal methods for expressing and purifying porcine coronavirus spike proteins for research:
Construct design:
Express the spike ectodomain (S-e) without the transmembrane anchor or intracellular tail
Exclude the hydrophobic pretransmembrane region to improve protein solubility
Add a C-terminal trimerization tag (such as GCN4) to stabilize the native trimeric structure
Consider introducing stabilizing mutations that lock the protein in the prefusion conformation
Expression systems:
Purification strategy:
Initial capture using affinity chromatography (such as Ni-NTA for His-tagged proteins)
Size-exclusion chromatography to separate properly folded trimers from aggregates and degradation products
Monitor protein quality by SDS-PAGE and negative-stain EM
This approach has successfully yielded high-quality porcine coronavirus spike proteins suitable for structural studies by cryo-EM and for immunological investigations, as demonstrated in the reviewed literature .
Structural studies of porcine coronavirus spike proteins provide several critical insights that can directly inform vaccine development:
Prefusion stabilization strategies:
The identification of non-protein components (glycans at specific sites like Asn264 and fatty acid molecules) that mediate protein-protein interfaces in PEDV spike suggests specific stabilization strategies
These stabilizing features can be enhanced through targeted mutations to lock spike proteins in their prefusion conformation, potentially improving immunogenicity
Immunodominant epitope identification:
Receptor-binding insights:
Cross-protective potential:
These structural insights enable rational vaccine design approaches that may improve upon traditional inactivated or attenuated virus vaccines by focusing immune responses on key neutralizing epitopes while maintaining the native prefusion conformation critical for inducing protective antibodies.
Research on porcine coronaviruses provides valuable insights into zoonotic potential and interspecies transmission of coronaviruses:
Evolutionary origins and host jumps:
SADS-CoV shows high genetic similarity to bat coronavirus HKU2, strongly suggesting a bat origin
PDCoV appears to have originated from avian deltacoronaviruses, with genetic evidence pointing to a common ancestry with sparrow coronaviruses
These documented host jumps demonstrate the real potential for cross-species transmission
Receptor adaptation mechanisms:
Pigs as potential "mixing vessels":
Structural similarities with human coronaviruses:
Understanding these aspects of porcine coronaviruses can inform surveillance strategies and risk assessment for emerging coronaviruses with zoonotic potential, contributing to pandemic preparedness efforts.
Despite significant advances, several important research gaps remain in our understanding of porcine coronavirus spike proteins:
Receptor interactions:
Structural dynamics:
Cross-protection mechanisms:
Comprehensive mapping of cross-reactive epitopes between different porcine coronaviruses
Understanding why certain antibodies provide cross-protection while others do not
Identification of truly conserved neutralizing epitopes across porcine coronaviruses
Spike protein variation:
Host-specific adaptation:
Molecular determinants that enable porcine coronaviruses to efficiently infect pig cells
Comparative studies with related coronaviruses from other hosts to identify key adaptive mutations
Understanding age-dependent susceptibility differences between piglets and adult swine
Addressing these research gaps would significantly advance our understanding of porcine coronavirus biology and potentially inform strategies for control and prevention of these economically important pathogens.
Interdisciplinary approaches are crucial for advancing porcine coronavirus research, as they can integrate diverse methodologies and perspectives to address complex questions. Combining structural biology techniques with immunology, virology, and epidemiology has already yielded important insights into porcine coronavirus spike proteins, as evidenced by the successful use of cryo-EM to determine spike structures and negative-stain EM to map antibody epitopes . Future research would benefit from further integration of computational biology, systems biology, and evolutionary analysis to better understand spike protein function, host interactions, and potential for cross-species transmission.
The Mouse Anti Porcine Coronavirus Spike Monoclonal Antibody, clone PTT1E11, is a specialized antibody developed for research and diagnostic purposes. This monoclonal antibody specifically targets the spike protein of porcine coronaviruses, which are significant pathogens affecting swine populations globally. The spike protein is a critical component of the coronavirus structure, responsible for virus entry into host cells.
Monoclonal antibodies are produced using hybridoma technology, which involves the fusion of an antibody-producing B cell with a myeloma (cancer) cell. This fusion results in a hybrid cell, or hybridoma, that can produce large quantities of a single type of antibody. The development of clone PTT1E11 involves the following steps:
The Mouse Anti Porcine Coronavirus Spike Monoclonal Antibody, clone PTT1E11, has several important applications in research and diagnostics: